0001723128-19-000040.txt : 20190312
0001723128-19-000040.hdr.sgml : 20190312
20190312164548
ACCESSION NUMBER: 0001723128-19-000040
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190312
FILED AS OF DATE: 20190312
DATE AS OF CHANGE: 20190312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BISARO PAUL
CENTRAL INDEX KEY: 0001237253
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38485
FILM NUMBER: 19675614
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001723128
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
BUSINESS PHONE: (908) 947-3120
MAIL ADDRESS:
STREET 1: 400 CROSSING BOULEVARD
STREET 2: 3RD FLOOR
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: Atlas Holdings, Inc.
DATE OF NAME CHANGE: 20171117
4
1
wf-form4_155242353408413.xml
FORM 4
X0306
4
2019-03-12
0
0001723128
Amneal Pharmaceuticals, Inc.
AMRX
0001237253
BISARO PAUL
C/O AMNEAL PHARMACEUTICALS, INC.
400 CROSSING BOULEVARD, 3RD FLOOR
BRIDGEWATER
NJ
08807
1
1
0
0
Executive Chairman
Class A Common Stock
2019-03-12
4
P
0
17000
11.97
A
17000
D
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.95 per share to $11.98 per share. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Brian P. Spitser, Attorney-in-Fact
2019-03-12